Phase I Study of Weekly Clofarabine for the Treatment of Relapsed/Refractory Chronic Lymphocytic Leukemia.
Phase of Trial: Phase I
Latest Information Update: 24 Aug 2013
At a glance
- Drugs Clofarabine (Primary)
- Indications B cell prolymphocytic leukaemia; Chronic lymphocytic leukaemia; T cell prolymphocytic leukaemia
- Focus Adverse reactions
- 31 Jul 2012 Additional lead trial investigator (Faderl S) added as reported by ClinicalTrials.gov.
- 29 Dec 2009 Status changed from completed to discontinued as reported by ClinicalTrials.gov.
- 11 Aug 2009 Actual end date (Jun 2007) added as reported by ClinicalTrials.gov.